Skip to main content
Premium Trial:

Request an Annual Quote

Craig Venter, Tony White, Fiona Brinkman

Premium

In a surprise move, Craig Venter stepped down as president of Celera Genomics last week. Tony White, chairman and CEO of Celera’s parent company, Applera, will take on the role of president until the company finds a replacement, while Venter will remain chair of Celera’s scientific advisory board.

“We are now at a critical juncture where my best contributions can be made in a scientific advisory role, allowing the rest of the organization to continue Celera’s progress toward becoming a successful pharmaceutical business,” said Venter, who also plans to spend more time in his role as chairman of the board of the Institute for Genomic Research, which he founded in 1992.

 

The Association for Computing Machinery is presenting Gene Myers, Celera’s vice president for informatics research, with the Paris Kanellakis Theory and Practice Award for his contribution to sequencing the human genome.

“Not only did Myers’ mathematical analyses and simulation studies establish the feasibility of the shotgun approach to sequencing large genomes, but he went on to design the algorithms that made the reconstruction of the genome possible,” said John White, executive director of ACM, in a statement.

ACM will present the Paris Kanellakis Award, which honors accomplishments that have had a significant effect on the practice of computing, on April 27 at the University of Toronto.

 

Vancouver-based Genops Bioinformatics has appointed Fiona Brinkman to its scientific advisory board. Brinkman is an assistant professor at Simon Fraser University. Her research focuses on the evolution of pathogens and the development of computational tools.

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.